China, India on rise as research partnersThe AustralianRESEARCH collaboration between Australia and China has nearly doubled in the past decade and India is on the rise as a research partner. ...Australia Substantially Increases Research Collaboration with China, According ...PR Newswire (press release)all 19 news articles »

DARKDaily.com - Laboratory NewsQuintiles Expands Its China Laboratory Services to Include Anatomic Pathology ...DARKDaily.com - Laboratory NewsWith this action, global CRO (clinical research organization) giant Quintiles is responding to the increasing sophistication of the pharmaceutical industry ...

Santarus, Inc. Q4 2009 Earnings Call TranscriptSeeking Alpha (blog)GSK also has committed a clinical trial application in China, which is similar to an IND application in the US, and plans to initiate clinical studies there ...and more »

Research and Markets: An Essential Report on Rheumatoid Arthritis Therapeutics ...Trading Markets (press release)In countries such as China, the Philippines, and India, which do not have extensive government reimbursement, the affordability of drugs is critical when ...and more »

Drug Discovery In India and China by BharatbookPRLog.Org (press release)Both countries are able to provide significant cost savings in the range of 60–70% for discovery research and clinical trials. With discovery research ...and more »

Drug Discovery in India and China - Gaining Momentum with Increasing Pressure ...PRLog.Org (press release)Both countries are able to provide significant cost savings in the range of 60–70% for discovery research and clinical trials. With discovery research ...and more »

Overlapping CrisesInside Higher EdThis vacuum is being filled by students from India and China. Walk down the hallways of science and engineering departments of American research ...and more »

Business Standard'China will snatch our market from us'Business StandardIf you ask me, they are waiting to see Daiichi Sankyo move its research work to India, because their ambition is to be with a global pharma innovator. ...and more »

China VS. India: Stock Picks From Citi Investment ResearchThe Wall Street Transcript (blog)And none of these companies have the financial muscle to take a molecule all the way through the clinical development part up to the market. ...

PPD completes acquisition of Chinese clinical trials company Excel pharmastudiesTriangle Business Journal“China is a strong, emerging area for clinical research as evidenced by its 21 percent compounded annual growth rate over the past five years,” said David ...PPD expands presence in China with acquisitionStarNewsOnline.comall 34 news articles »